Spots Global Cancer Trial Database for thymoglobulin
Every month we try and update this database with for thymoglobulin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Allogeneic Hematopoietic Stem Cell Transplantation | NCT00750126 | Solid Tumors Hematologic Neo... | Fludarabine, Bu... | - 20 Years | University Hospital, Clermont-Ferrand | |
| Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies | NCT01622556 | Hematologic Mal... | Fludarabine Busulfan Thymoglobulin Total Body Irra... Umbilical Cord ... | 18 Years - 70 Years | University of Virginia | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor | NCT06083129 | GVHD | Grafalon Thymoglobulin | 50 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients | NCT02877082 | Acute Leukemia Chronic Lymphoc... Chronic Myeloge... Diffuse Large B... Follicular Lymp... Graft Versus Ho... Mantle Cell Lym... Marginal Zone L... Myelodysplastic... Myelofibrosis Myeloproliferat... Small Lymphocyt... | Thymoglobulin Bortezomib Tacrolimus | 18 Years - 75 Years | Emory University | |
| Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients | NCT00499889 | Leukemia | Imatinib Mesyla... Fludarabine (Fl... Busulfan Antithymocyte G... Tacrolimus Methotrexate Donor lymphocyt... Stem Cell Trans... | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome | NCT00475020 | Myelofibrosis | Busulfan Fludarabine Thymoglobulin (... | - 75 Years | M.D. Anderson Cancer Center | |
| Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT01471444 | Disorder Relate... Leukemia Transplantation... | Fludarabine Clofarabine Busulfan Thymoglobulin Stem Cell Infus... Tacrolimus Methotrexate | 3 Years - 70 Years | M.D. Anderson Cancer Center | |
| Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus | NCT00133367 | Multiple Myelom... Non-Hodgkin's L... Hodgkin's Disea... Myelogenous Leu... Lymphoblastic L... | Tacrolimus Sirolimus G-CSF Antithymocyte g... Thymoglobulin Fludarabine Melphalan | 18 Years - 65 Years | Massachusetts General Hospital | |
| Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation | NCT00990249 | Leukemia Lymphoma Allogeneic Haem... Acute Lymphobla... | Busulfan Clofarabine Thymoglobulin Stem Cell Trans... | - 65 Years | M.D. Anderson Cancer Center | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) With Busulfan, Fludarabine and Thymoglobulin | NCT00822770 | Stem Cell Trans... Leukemia | Plerixafor Filgrastim Fludarabine Busulfan Allogeneic bloo... ATG (Thymoglobu... | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation | NCT00593645 | Myelodysplastic... Acute Myeloid L... | Clofarabine Cytarabine Thymoglobulin Stem cell infus... | 18 Years - | Washington University School of Medicine | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning | NCT03852407 | Acute Myeloid L... Myelodysplastic... Chronic Myeloid... Myeloproliferat... Myeloproliferat... Acute Lymphoid ... Multiple Myelom... Chronic Lymphoi... Non Hodgkin Lym... Hodgkin Lymphom... | Thymoglobulin Melphalan Fludarabine Cyclophosphamid | 18 Years - 75 Years | University of Liege | |
| Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT | NCT02627573 | Leukemia, Chron... Myelodysplastic... Leukemia, Myelo... | Unrelated allog... Busulfan Fludarabine mon... Tacrolimus Mycophenolate m... Cyclophosphamid... Thymoglobulin | 18 Years - 75 Years | St. Petersburg State Pavlov Medical University | |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma | NCT00506129 | Lymphoma Disorder Relate... | Fludarabine Melphalan Allogeneic Tran... Thymoglobulin | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors | NCT00679536 | Leukemia | Busulfan Fludarabine Thymoglobulin Total Body Irra... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma | NCT00506129 | Lymphoma Disorder Relate... | Fludarabine Melphalan Allogeneic Tran... Thymoglobulin | - 70 Years | M.D. Anderson Cancer Center | |
| Infusion of Expanded Cord Blood T Cells | NCT00972101 | Stem Cell Trans... Leukemia Lymphoma Pediatric Disor... | Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande... | - 55 Years | M.D. Anderson Cancer Center | |
| Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML | NCT00669890 | Acute Myeloid L... Juvenile Myelom... Myelodysplastic... | Gemtuzumab Ozog... Busulfan Cyclophosphamid... Thymoglobulin Tacrolimus Mycophenolate M... Methotrexate | - 30 Years | New York Medical College | |
| Phase III Study Comparing GVHD Prophylaxis With ATG-thymoglobulin to ATLG-grafalon in Elderly Patients With Acute Myeloid Leukemia or Myelodysplasic Syndrome and Receiving an Allogeneic Hematopoietic Stem Cell Transplantation With a 10/10 HLA Matched Unrelated Donor | NCT06083129 | GVHD | Grafalon Thymoglobulin | 50 Years - 70 Years | Assistance Publique - Hôpitaux de Paris | |
| Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma | NCT00506129 | Lymphoma Disorder Relate... | Fludarabine Melphalan Allogeneic Tran... Thymoglobulin | - 70 Years | M.D. Anderson Cancer Center | |
| Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders | NCT01392989 | Neural Tube Def... Anemia Leukemia, Myelo... Bone Marrow Tra... Myelodysplastic... Myeloproliferat... | CIK cells Cyclosporine Mycophenolate M... Thymoglobulin Total Lymphoid ... | 50 Years - | Stanford University | |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies | NCT00476229 | Lymphoma Leukemia | Thymoglobulin Total Lymphoid ... Peripheral Bloo... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies | NCT00476229 | Lymphoma Leukemia | Thymoglobulin Total Lymphoid ... Peripheral Bloo... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00402558 | Myelodysplastic... Leukemia | Thymoglobulin Busulfan Fludarabine Alloreactive NK... G-CSF Tacrolimus Methotrexate Interleukin-2 | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Transplantation for Pediatric Leukemias With Unrelated Donors | NCT00679536 | Leukemia | Busulfan Fludarabine Thymoglobulin Total Body Irra... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Nonmyeloablative Stem Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) | NCT00899431 | Chronic Lymphoc... | Lenalidomide Fludarabine Rituximab Thymoglobulin Stem Cell Trans... Bendamustine Allopurinol | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome | NCT00806598 | Myelodysplastic... Aplastic Anemia | Thymoglobulin Cyclosporine Methylprednisol... G-CSF | 15 Years - | M.D. Anderson Cancer Center | |
| Busulfan Plus Clofarabine Followed by Allogeneic Hematopoietic Stem Cell Transplantation | NCT00990249 | Leukemia Lymphoma Allogeneic Haem... Acute Lymphobla... | Busulfan Clofarabine Thymoglobulin Stem Cell Trans... | - 65 Years | M.D. Anderson Cancer Center | |
| Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT | NCT00709592 | Non-Hodgkin's L... Leukemia Multiple Myelom... Acute Myeloid L... Hodgkin Lymphom... Chronic Lymphoc... Chronic Myeloge... Myelodysplastic... | Thymoglobulin Total-Body Irra... Allogeneic PBSC... Tacrolimus Mycophenolate M... | 40 Years - 70 Years | Virginia Commonwealth University | |
| Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation | NCT00593645 | Myelodysplastic... Acute Myeloid L... | Clofarabine Cytarabine Thymoglobulin Stem cell infus... | 18 Years - | Washington University School of Medicine | |
| Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) | NCT00402558 | Myelodysplastic... Leukemia | Thymoglobulin Busulfan Fludarabine Alloreactive NK... G-CSF Tacrolimus Methotrexate Interleukin-2 | - 70 Years | M.D. Anderson Cancer Center | |
| Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor | NCT00523809 | Breast Cancer Ovarian Cancer | Bevacizumab Allogeneic Hema... Fludarabine Melphalan Thymoglobulin | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma | NCT00670410 | Neuroblastoma | Related donor t... Cord blood tran... Busulfan Thymoglobulin Fludarabine | - 30 Years | Columbia University | |
| Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies | NCT00521859 | Hematologic Mal... | Cloretazine Fludarabine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | NCT00303667 | Acute Myelogeno... | aldesleukin natural killer ... cyclophosphamid... fludarabine pho... allogeneic hema... total body irra... Thymoglobulin Cyclosporin A cyclophosphamid... fludarabine pho... | 18 Years - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML | NCT00669890 | Acute Myeloid L... Juvenile Myelom... Myelodysplastic... | Gemtuzumab Ozog... Busulfan Cyclophosphamid... Thymoglobulin Tacrolimus Mycophenolate M... Methotrexate | - 30 Years | New York Medical College | |
| Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML) | NCT02441803 | Leukemia | Busulfan Fludarabine Clofarabine Total Body Irra... Thymoglobulin Stem Cell Infus... Cyclophosphamid... Tacrolimus Mycophenolate m... Decitabine Cytarabine Idarubicin | 18 Years - 60 Years | M.D. Anderson Cancer Center | |
| Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells | NCT01362452 | Leukemia Lymphoma | T-Cell Infusion Cord Blood Infu... | 1 Year - 75 Years | M.D. Anderson Cancer Center | |
| Pilot Study of Unrelated Cord Blood Transplantation | NCT00916045 | Leukemia, Myelo... Myelodysplastic... Leukemia, Lymph... Lymphoma, Non-H... Hodgkin Disease Chronic Lymphoc... | Thiotepa Fludarabine Intravenous bus... Thymoglobulin Ciclosporin Mycophenolate m... Fludarabine Cyclophosphamid... Radiotherapy Thymoglobulin Ciclosporin Mycophenolate m... Fludarabine Melphalan Thymoglobulin Ciclosporin Mycophenolate m... | 18 Years - 70 Years | King's College Hospital NHS Trust | |
| Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies | NCT00476229 | Lymphoma Leukemia | Thymoglobulin Total Lymphoid ... Peripheral Bloo... Rituximab | - 70 Years | M.D. Anderson Cancer Center | |
| Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies | NCT01471067 | Blood And Marro... Leukemia Lymphoma Transplantation... Transplantation... | Melphalan Fludarabine Mycophenolate m... Tacrolimus Cord Blood Infu... Rituximab ATG Busulfan Clofarabine Total Body Irra... | 1 Year - 80 Years | M.D. Anderson Cancer Center | |
| Donor Natural Killer Cells and Aldesleukin in Treating Patients w/High Risk AML Undergoing Donor Stem Cell Transplant | NCT00303667 | Acute Myelogeno... | aldesleukin natural killer ... cyclophosphamid... fludarabine pho... allogeneic hema... total body irra... Thymoglobulin Cyclosporin A cyclophosphamid... fludarabine pho... | 18 Years - 70 Years | Masonic Cancer Center, University of Minnesota | |
| Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies | NCT00521859 | Hematologic Mal... | Cloretazine Fludarabine | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Infusion of Expanded Cord Blood T Cells | NCT00972101 | Stem Cell Trans... Leukemia Lymphoma Pediatric Disor... | Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande... | - 55 Years | M.D. Anderson Cancer Center | |
| Infusion of Expanded Cord Blood T Cells | NCT00972101 | Stem Cell Trans... Leukemia Lymphoma Pediatric Disor... | Total Body Irra... Melphalan Thiotepa Fludarabine Rituximab Etoposide Anti-thymocyte ... Mycophenolate M... Tacrolimus Cord Blood Infu... G-CSF Ex vivo expande... | - 55 Years | M.D. Anderson Cancer Center | |
| Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders | NCT01392989 | Neural Tube Def... Anemia Leukemia, Myelo... Bone Marrow Tra... Myelodysplastic... Myeloproliferat... | CIK cells Cyclosporine Mycophenolate M... Thymoglobulin Total Lymphoid ... | 50 Years - | Stanford University | |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies | NCT00857389 | Stem Cell Trans... Leukemia Lymphoma | Thiotepa Clofarabine Busulfan Allogeneic Stem... Thymoglobulin (... G-CSF (Filgrast... Tacrolimus Methotrexate Cyclophosphamid... Mesna | - 60 Years | M.D. Anderson Cancer Center | |
| Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT | NCT00709592 | Non-Hodgkin's L... Leukemia Multiple Myelom... Acute Myeloid L... Hodgkin Lymphom... Chronic Lymphoc... Chronic Myeloge... Myelodysplastic... | Thymoglobulin Total-Body Irra... Allogeneic PBSC... Tacrolimus Mycophenolate M... | 40 Years - 70 Years | Virginia Commonwealth University | |
| Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease | NCT00385788 | Hodgkin's Disea... | Gemcitabine Fludarabine Melphalan Antithymocyte G... Allogeneic Stem... Tacrolimus Filgrastim (G-C... Methotrexate | - 65 Years | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
